TODD STRATEGY GROUP

Lobbying for ILLUMINA, INC. · Biotechnology company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $80,000.00 income · posted Apr 20, 2026

Lobbying activity 3

Health Issues

General discussions related to FDA regulation of diagnostics.

Medicare/Medicaid

General discussions related to Medicare reimbursement for diagnostic tests.

Trade (domestic/foreign)

General trade issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.